Abstract
ZMIZ1 acts as an oncogene in hepatocellular carcinoma (HCC). circZMIZ1 (hsa_circ_0018964) derives from ZMIZ1; its underlying mechanism in HCC has not been reported. Peripheral blood and peripheral blood mononuclear cells (PBMCs) were obtained from HCC patients and healthy volunteers. CD8+ T cells were sorted from PBMCs of HCC patients. Applying flow cytometry, cell apoptosis and the proportion of KCNJ2/CD8+ T cells were examined. The cytotoxicity of CD8+ T cells against HCC cells was evaluated. The interaction among circZMIZ1, miR-15a-5p, and KCNJ2 was investigated by dual luciferase assay, RNA immunoprecipitation, and RNA pull-down assay. An orthotopic mouse model of HCC was constructed by intrahepatic injection of H22 cells. Upregulation of circZMIZ1 and KCNJ2 and downregulation of miR-15a-5p were observed in peripheral blood and PBMCs of HCC patients. The proportion of KCNJ2/CD8+ T cells was also increased in HCC patients. circZMIZ1 knockdown restrained apoptosis of CD8+ T cells and elevated cytotoxicity of CD8+ T cells. Mechanically speaking, circZMIZ1 elevated KCNJ2 expression by sponging miR-15a-5p. miR-15a-5p inhibitor reversed circZMIZ1 silencing-mediated inhibition of apoptosis and promotion of cytotoxicity in CD8+ T cells. In vivo, orthotopic mice of HCC exhibited increased expression of circZMIZ1 and KCNJ2, elevated proportion of KCNJ2/CD8+ T cells, and decreased expression of miR-15a-5p. This work demonstrated that circZMIZ1 inhibited the anti-tumor activity of CD8+ T cells in HCC by regulating the miR-15a-5p/KCNJ2 axis. This provides a theoretical basis for the development of effective circZMIZ1 in tumor immunotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No datasets were generated or analyzed during the current study.
References
Bian J, Lin J, Long J et al (2020) T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy. Am J Cancer Res 10:4585–4606
Bizzarri AR, Cannistraro S (2021) Direct interaction of miRNA and circRNA with the oncosuppressor p53: an intriguing perspective in cancer research. Cancers (Basel) 13(23):6108. https://doi.org/10.3390/cancers13236108
Bright RK, Bright JD, Byrne JA (2014) Overexpressed oncogenic tumor-self antigens. Hum Vaccin Immunother 10:3297–3305. https://doi.org/10.4161/hv.29475
Chen S, Huang M, Hu X (2021) Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression. Mol Med Rep 24. https://doi.org/10.3892/mmr.2021.12261
Ding B, Fan W, Lou W (2020) hsa_circ_0001955 Enhances in vitro proliferation, migration, and invasion of HCC cells through miR-145-5p/NRAS axis. Mol Ther Nucleic Acids 22:445–455. https://doi.org/10.1016/j.omtn.2020.09.007
Gagnon JD, Ansel KM (2019) MicroRNA regulation of CD8(+) T cell responses. Noncoding RNA Investig 3. https://doi.org/10.21037/ncri.2019.07.02
Gong Y, Mao J, Wu D et al (2018) Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6. Cancer Cell Int 18:116. https://doi.org/10.1186/s12935-018-0602-3
He Y, Huang H, Jin L et al (2020) CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions. Cell Death Dis 11:358. https://doi.org/10.1038/s41419-020-2441-0
Huang XY, Zhang PF, Wei CY et al (2020) Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer 19:92. https://doi.org/10.1186/s12943-020-01213-6
Ji CD, Wang YX, Xiang DF et al (2018) Kir2.1 interaction with Stk38 promotes invasion and metastasis of human gastric cancer by enhancing MEKK2-MEK1/2-ERK1/2 signaling. Cancer Res 78:3041–3053. https://doi.org/10.1158/0008-5472.can-17-3776
Jiang H, Lv DJ, Song XL et al (2020) Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma. Neoplasma 67:68–77. https://doi.org/10.4149/neo_2019_190213N116
Jiang Y, Li Y, Zhu B (2015) T-cell exhaustion in the tumor microenvironment. Cell Death Dis 6:e1792. https://doi.org/10.1038/cddis.2015.162
Liang Z, Sun R, Tu P et al (2022) Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. Front Immunol 13:944286. https://doi.org/10.3389/fimmu.2022.944286
Liu H, Huang J, Peng J et al (2015) Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Mol Cancer 14:59. https://doi.org/10.1186/s12943-015-0298-0
Liu J, Sun T, Yin L (2023) ZMIZ1 Upregulation of TET3-mediated hydroxymethylation induces M2 polarization of Kupffer cells in hepatocellular carcinogenesis by mediating Notch1/c-Myc signaling. Lab Invest 103:100264. https://doi.org/10.1016/j.labinv.2023.100264
Lomelí H (2022) ZMIZ proteins: partners in transcriptional regulation and risk factors for human disease. J Mol Med (Berl) 100:973–983. https://doi.org/10.1007/s00109-022-02216-0
Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E, Mortezaee K (2019) Tumor microenvironment: Interactions and therapy. J Cell Physiol 234(5):5700–5721. https://doi.org/10.1002/jcp.27425
Ni Y, Yang Y, Ran J et al (2020) miR-15a-5p inhibits metastasis and lipid metabolism by suppressing histone acetylation in lung cancer. Free Radic Biol Med 161:150–162. https://doi.org/10.1016/j.freeradbiomed.2020.10.009
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660
Tiwari A, Trivedi R, Lin SY (2022) Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci 29:83. https://doi.org/10.1186/s12929-022-00866-3
Wang Q, Yu W, Wang T et al (2023) Circular RNA circDLG1 contributes to HCC progression by regulating the miR-141-3p/WTAP axis. Funct Integr Genom 23:179. https://doi.org/10.1007/s10142-023-01096-y
Wang T, Xu C, Zhang Z et al (2022a) Cellular heterogeneity and transcriptomic profiles during intrahepatic cholangiocarcinoma initiation and progression. Hepatology 76:1302–1317. https://doi.org/10.1002/hep.32483
Wang X, Wang J, Shen H et al (2022b) Downregulation of TPX2 impairs the antitumor activity of CD8+ T cells in hepatocellular carcinoma. Cell Death Dis 13:223. https://doi.org/10.1038/s41419-022-04645-8
Wu G, Fan X, Sun L (2015) Silencing of Wnt10B reduces viability of heptocellular carcinoma HepG2 cells. Am J Cancer Res 5:1911–1920
Xie F, Xiao P, Chen D, Zhang BH (2012) miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol 80:75–84. https://doi.org/10.1007/s11103-012-9885-2
Yan L, Chen Y, Han Y et al (2022) Role of CD8(+) T cell exhaustion in the progression and prognosis of acute respiratory distress syndrome induced by sepsis: a prospective observational study. BMC Emerg Med 22:182. https://doi.org/10.1186/s12873-022-00733-2
Yang SK, Hong M, Choi H et al (2015) Immunochip analysis identification of 6 additional susceptibility loci for Crohn’s disease in Koreans. Inflamm Bowel Dis 21:1–7. https://doi.org/10.1097/mib.0000000000000268
Zhang HJ, Liu Z, Kan L (2022) Prostate cancer susceptibility loci identified in GATA2 and ZMIZ1 in Chinese population. Int J Genomics 2022:8553530. https://doi.org/10.1155/2022/8553530
Zhang HY, Liang HX, Wu SH et al (2021) Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression. Front Oncol 11:622263. https://doi.org/10.3389/fonc.2021.622263
Zhou X, Xiao Q, Jiang F et al (2023) Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk. Br J Cancer 129:1306–1313. https://doi.org/10.1038/s41416-023-02397-6
Author information
Authors and Affiliations
Contributions
XL, AW, and YW: conceptualization, data curation, formal analysis, and writing–original draft preparation.
XL, AW, and DL: conceptualization, methodology, and writing–original draft preparation.
MW: supervision, writing, review, and editing.
All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics statement
All the study protocols were approved by the Ethics Committee of the Second Affiliated Hospital of Nanchang University and were conducted according to the principles of the Declaration of Helsinki.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, X., Wu, A., Wang, Y. et al. Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8+ T cells to alleviate hepatocellular carcinoma. Funct Integr Genomics 24, 27 (2024). https://doi.org/10.1007/s10142-024-01302-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10142-024-01302-5